ONCAlert | 2017 San Antonio Breast Cancer Symposium

Treating a Patient With HER2-Negative Chemotherapy-Resistant mBC

Ragene Rivera, MD
Published Online:5:50 PM, Tue August 12, 2014
Ragene Rivera, MD, medical oncologist, Texas Oncology-El Paso Cancer Treatment Center, discusses the next treatment steps for a patient with HER2-negative chemotherapy-resistant metastatic breast cancer.

This segment is a part of our Case-Based Peer Perspectives. View the case details > >
Copyright © TargetedOnc 2017 Intellisphere, LLC. All Rights Reserved.